Masterson Richard Kevin 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 14, 2012
Insider Transaction Report
Form 4
Masterson Richard Kevin
Pres.&COO, Valeant Int.(BB)SRL
Transactions
- Sale
Common Stock, no par values
2012-05-10$52.57/sh−4$210→ 89,524 total
Footnotes (2)
- [F1]Represents the amount of shares sold to cover fees to have previously vested shares transferred from the company's equity provider to the officer's personal account.
- [F2]This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1.